News Low Binding Affinity Can Be Advantageous for Vaccines A research team has succeeded in producing a new vaccine against the SARS-CoV-2 coronavirus by identifying spike protein mutants that lack binding affinity.
Technology Networks,
Listen with Speechify Register for free to listen to this article Thank you. Listen to this article using the player above.